3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
123
Recurrence
12
Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
5
Smoldering Multiple Myeloma
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Plasmacytoma
2
Plasmablastic Lymphoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Amyloidosis
2
Acute Kidney Injury
2
Triple Negative Breast Neoplasms
1
Proteostasis Deficiencies
1
Primary Myelofibrosis
1
Paraproteinemias
1
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cytarabine
4
Azacitidine
4
venetoclax
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Biopsy
3
pegylated granulocyte colony-stimulating factor
2
Tacrolimus
2
Mitoxantrone
2
Gemtuzumab
2
Decitabine
2
Daunorubicin
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
Bone Marrow Transplantation
2
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
fedratinib
1
enasidenib
1
aldesleukin
1
Thiotepa
1
Spinal Puncture
1
Specimen Handling
1
Social Determinants of Health
1
Sirolimus
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mycophenolic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
daratumumab
×
1 year
×
Clear all
No trials found.